Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
5% capsaicin topical liquid (CGS-200-5) / Astellas
ASKC200, NCT06614608: The Safety and Pharmacokinetics of in Osteoarthritic Knee Pain	Not yet recruiting	1	24	RoW	5% ASKC200, 1% ASKC200	Jiangsu Aosaikang Pharmaceutical Co., Ltd.	Osteoarthritis, Knee, Pain	04/25	12/25
abiraterone decanoate (ASP5541) / Astellas
NCT07005154: A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer	Not yet recruiting	2	218	NA	ASP5541, PRL-02, Prednisone, Prednisolone, abiraterone acetate	Astellas Pharma Global Development, Inc.	Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer	05/32	05/32
PRL-02-1001, NCT04729114: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer	Recruiting	1	174	US	PRL-02 injection, prednisone, dexamethasone, enzalutamide	Astellas Pharma Global Development, Inc.	Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer	08/25	05/29

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
5% capsaicin topical liquid (CGS-200-5) / Astellas
ASKC200, NCT06614608: The Safety and Pharmacokinetics of in Osteoarthritic Knee Pain	Not yet recruiting	1	24	RoW	5% ASKC200, 1% ASKC200	Jiangsu Aosaikang Pharmaceutical Co., Ltd.	Osteoarthritis, Knee, Pain	04/25	12/25
abiraterone decanoate (ASP5541) / Astellas
NCT07005154: A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer	Not yet recruiting	2	218	NA	ASP5541, PRL-02, Prednisone, Prednisolone, abiraterone acetate	Astellas Pharma Global Development, Inc.	Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer	05/32	05/32
PRL-02-1001, NCT04729114: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer	Recruiting	1	174	US	PRL-02 injection, prednisone, dexamethasone, enzalutamide	Astellas Pharma Global Development, Inc.	Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer	08/25	05/29